Immunomodulatory effects of polysaccharopeptide in immunosuppressed mice induced by cyclophosphamide

Molecular Medicine Reports

Volumn 8, Issue 2, 2013, Pages 669-675

  Huang, Rui ^a   Zhang, Jun ^a   Liu, Yong ^b   Hao, Yingying ^b   Yang, Chenchen ^b   Wu, Kangkang ^b   Cao, Shufeng ^b   Wu, Chao ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Immune; Polysaccharopeptide; T lymphocyte subsets; Th1 Th2

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; POLYSACCHAROPEPTIDE; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNOMODULATION; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYMUS;

ANIMALS; CYCLOPHOSPHAMIDE; GENE EXPRESSION REGULATION; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MICE; PROTEOGLYCANS; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TIME FACTORS;

MUS;

EID: 84879898219     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1542     Document Type: Article

References (55)

1. Hyde HA and Adams KF: Airborne allergens at Cardiff 1942-59. Acta Allergol Suppl (Copenh) 7: 159-169, 1960.
2. Chu KK, Ho SS and Chow AH: Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol 42: 976-984, 2002.
3. Yang MM, Chen Z and Kwok JS: The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV). Am J Chin Med 20: 221-232, 1992.
4. Cui J and Chisti Y: Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv 21: 109-122, 2003.
5. Ng TB: A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 30: 1-4, 1998.
6. Kidd PM: The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5: 4-27, 2000.
7. Collins RA and Ng TB: Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection. Life Sci 60: PL383-PL387, 1997.
8. Yang X, Sit WH, Chan DK and Wan JM: The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. Oncol Rep 13: 1201-1210, 2005.
9. Li J, Bao Y, Lam W, et al: Immunoregulatory and anti-tumor effects of polysaccharopeptide and Astragalus polysaccharides on tumor-bearing mice. Immunopharmacol Immunotoxicol 30: 771-782, 2008.
10. Li W, Liu M, Lai S, Xu C, Lu F, Xiao X and Bao Y: Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways. Immunopharmacol Immunotoxicol 32: 576-584, 2010.
11. Lee CL, Jiang PP, Sit WH and Wan JM: Proteome of human T lymphocytes with treatment of cyclosporine and polysaccharopeptide: analysis of significant proteins that manipulate T cells proliferation and immunosuppression. Int Immunopharmacol 7: 1311-1324, 2007.
12. Shin H and Wherry EJ: CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 19: 408-415, 2007.
13. Wherry EJ: T cell exhaustion. Nat Immunol 12: 492-499 2011.
14. Huyan XH, Lin YP, Gao T, Chen RY and Fan YM: Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb/c mice. Int Immunopharmacol 11: 1293-1297, 2011.
15. Tornatore KM, Reed K and Venuto R: 24-hour immunologic assessment of CD4+ and CD8+ lymphocytes in renal transplant recipients receiving chronic methylprednisolone. Clin Nephrol 44: 290-298, 1995.
16. Huang GC, Wu LS, Chen LG, Yang LL and Wang CC: Immuno-enhancement effects of Huang Qi Liu Yi Tang in a murine model of cyclophosphamide-induced leucopenia. J Ethnopharmacol 109: 229-235, 2007.
17. de Jonge ME, Huitema AD, Rodenhuis S and Beijnen JH: Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 44: 1135-1164, 2005.
18. Schiavoni G, Mattei F, Di Pucchio T, Santini SM, Bracci L, Belardelli F and Proietti E: Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer. Blood 95: 2024-2030, 2000.
19. Zhu XL, Chen AF and Lin ZB: Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 111: 219-226, 2007.
20. Bafna AR and Mishra SH: Immunostimulatory effect of methanol extract of Curculigo orchioides on immunosuppressed mice. J Ethnopharmacol 104: 1-4, 2006.
21. Bafna AR and Mishra SH: Protective effect of bioactive fraction of Sphaeranthus indicus Linn. against cyclophosphamide induced suppression of humoral immunity in mice. J Ethnopharmacol 104: 426-429, 2006.
22. Gergely P: Drug-induced lymphopenia: focus on CD4+ and CD8+ cells. Drug Saf 21: 91-100, 1999.
23. Bao YX, Wong CK, Leung SF, et al: Clinical studies of immunomodulatory activities of Yunzhi-Danshen in patients with nasopharyngeal carcinoma. J Altern Complement Med 12: 771-776, 2006.
24. Wong CK, Bao YX, Wong EL, Leung PC, Fung KP and Lam CW: Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 33: 381-395, 2005.
25. Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature 383: 787-793, 1996.
26. Warren HS, Vogel FR and Chedid LA: Current status of immunological adjuvants. Annu Rev Immunol 4: 369-388, 1986.
27. Blachère NE, Morris HK, Braun D, Saklani H, Di Santo JP, Darnell RB and Albert ML: IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J Immunol 176: 7288-7300, 2006.
28. Lafreniere JF, Mills P, Bouchentouf M and Tremblay JP: Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res 312: 1127-1141, 2006.
29. Bowen H, Kelly A, Lee T and Lavender P: Control of cytokine gene transcription in Th1 and Th2 cells. Clin Exp Allergy 38: 1422-1431, 2008.
30. Ho CY, Lau CB, Kim CF, et al: Differential effect of Coriolus versicolor (Yunzhi) extract on cytokine production by murine lymphocytes in vitro. Int Immunopharmacol 4: 1549-1557, 2004.
31. Lee CL, Sit WH, Jiang PP, So IW and Wan JM: Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2 cytokine balance for suppression of activated human T cell proliferation by MAPKp38 and STAT5 pathways. J Pharm Pharmacol 60: 1491-1499, 2008.
32. Baecher-Allan C, Brown JA, Freeman GJ and Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167: 1245-1253, 2001.
33. Fowler S and Powrie F: Control of immune pathology by IL-10-secreting regulatory T cells. Springer Semin Immunopathol 21: 287-294, 1999.
34. Powrie F, Carlino J, Leach MW, Mauze S and Coffman RL: A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 183: 2669-2674, 1996.
35. Sakaguchi S, Ono M, Setoguchi R, et al: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27, 2006.
36. Hori S, Nomura T and Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003.
37. Wan YY and Flavell RA: Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770, 2007.
38. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA and Rudensky AY: Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775, 2007.
39. Ishida Y, Agata Y, Shibahara K and Honjo T: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11: 3887-3895, 1992.
40. Okazaki T, Iwai Y and Honjo T: New regulatory co-receptors: inducible co-stimulator and PD-1. Curr Opin Immunol 14: 779-782, 2002.
41. Chen L: Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4: 336-347, 2004.
42. Greenwald RJ, Freeman GJ and Sharpe AH: The B7 family revisited. Annu Rev Immunol 23: 515-548, 2005.
43. Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ and Sharpe AH: Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 33: 2706-2716, 2003.
44. Rodig N, Ryan T, Allen JA, et al: Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 33: 3117-3126, 2003.
45. Seo SK, Seo HM, Jeong HY, et al: Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response. Immunol Lett 102: 222-228, 2006.
46. Ding H, Wu X and Gao W: PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis. Clin Immunol 115: 184-191, 2005.
47. Ishida M, Iwai Y, Tanaka Y, Okazaki T, Freeman GJ, Minato N and Honjo T: Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett 84: 57-62, 2002.
48. Parry RV, Chemnitz JM, Frauwirth KA, et al: CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25: 9543-9553, 2005.
49. Chemnitz JM, Parry RV, Nichols KE, June CH and Riley JL: SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 173: 945-954, 2004.
50. Kim HK, Guan H, Zu G, et al: High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals. J Leukoc Biol 79: 686-695, 2006.
51. Barber DL, Wherry EJ, Masopust D, et al: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687, 2006.
52. Fiorentino DF, Bond MW and Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095, 1989.
53. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA and Mosmann TR: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248: 1230-1234, 1990.
54. Mosser DM and Zhang X: Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226: 205-218, 2008.
55. O'Garra A and Vieira P: T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7: 425-428, 2007. Government Program